Kolosis Bio and nonprofit MTF Biologics are launching Summit Matrix, a synthetic bone graft for spine and orthopedic surgeries.
The bone graft is supported by NanoLift surface technology and designed to improve bone regeneration, according to a Jan. 14 news release. Summit Matrix’s hydroxycarbanoapatite composition mimics natural bone mineral for resorption and osseointegration.
MTF Biologics and Kolosis have partnered for past biologic launches including Kore Fiber, Prime HD, DBX Mix and DBX Putty.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
